Literatura

Seznam literatury koresponduje s odkazy v tabulkách 1 a 2. Pro více informací hledejte na PubMed. * Určeno pro odbornou veřejnost.

Abstrakta ze 7. mezinárodní konference proti rakovině
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E. & Thun, M. (2003) Cancer statistics, 2003. CA Cancer J. Clin. 53: 5–26.
Kelloff, G. J., Hawk, E. T., Karp, J. E., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R. A. & Sigman, C. C. (1997) Progress in clinical chemoprevention. Semin. Oncol. 24: 241–252.
Shamsuddin, A. M. (2002) Anti-cancer function of phytic acid. Int. J. Food Sci. Technol. 37: 769–782.
Shamsuddin, A. M., Vucenik, I. & Cole, K. E. (1997) IP6: a novel anti-cancer agent. Life Sci. 61: 343–354.
Shamsuddin, A. M. (1995) Inositol phosphates have novel anticancer function. J. Nutr. 125: 725S–732S.
Harland, B. F. & Oberleas, D. (1987) Phytate in foods. World Rev. Nutr. Diet. 52: 235–259.
Reddy, N. R., Sathe, S. K. & Salunke, D. K. (1982) Phytates in legumes and cereals. Adv. Food Res. 28: 1–89
Berridge, M. J. & Irvine, R. F. (1989) Inositol phosphates and cell signalling. Nature 341: 197–205.
Menniti, F. S., Oliver, K. G., Pytney, J. W., Jr. & Shears, S. B. (1993) Inositol phosphates and cell signalling: new view of InsP5 and InsP6. Trends Biochem. Sci. 18: 53–65
Sasakawa, N., Sharif, M. & Hanley, M. R. (1995) Metabolism and biological activities of inositol pentakisphosphates and inositol hexakisphosphate. Biochem. Pharmacol. 50: 137–146.
Graf, E. & Eaton, J. W. (1990) Antioxidant functions of phytic acid. Free Radi. Biol. Med. 8: 61–69.
Huisaman, B. & Lochner, A. (1996) Inositol polyphosphates and their binding proteins-a short review. Mol. Cell. Biochem. 157: 229–232.
Shears, S. B. (1996) Inositol pentakis- and hexakisphosphate metabolism adds versatility to the actions of inositol polyphosphates: novel effects on ion channels and protein traffic. Subcell. Biochem. 26: 187–226.
Larsson, O., Barker, C. J., Sjöholm, A., Carlqvist, H., Mitchell, R. H., Bertorello, A., Nilsson, T., Honkanen, R. E., Mayr, G. W., Zwiller, J. & Berggren, P.-O. (1997) Inhibition of phosphatases and increased Ca2+ channel activity by inositol hexakisphosphate. Science 278: 471–474.
Zi, X., Singh, R. P. & Agarwal, R. (2000) Impairment of erbB1 receptor and fluid phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Carcinogenesis 21: 2225–2235.
Efanov, A. M., Zaitsev, S. V. & Berggren, P.-O. (1997) Inositol hexakisphosphate stimulates non-Ca2+-mediated and primes Ca2+-mediated exocytosis of insulin by activation of protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 94: 4435–4439.
York, J. D., Odom, A. R., Murphy, R., Ives, E. B. & Wente, S. R. (1999) A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science 285: 96–100.
Shamsuddin, A. M., Elsayed, A. & Ullah, A. (1988) Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate. Carcinogenesis 9: 577–580.
Shamsuddin, A. M., Ullah, A. & Chakravarthy, A. (1989) Inositol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 10: 1461–1463.
Shamsuddin, A. M. & Ullah, A. (1989) Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 10: 625–626.
Vucenik, I. & Shamsuddin, A. M. (1994) [3H]-Inositol hexaphosphate (phytic acid) is rapidly absorbed and metabolized by murine and human malignant cells in vitro. J. Nutr. 124: 861–868.
Sakamoto, K., Vucenik, I. & Shamsuddin, A. M. (1993) [3H]Phytic acid (inositol hexaphosphate) is absorbed and distributed to various tissues in rats. J. Nutr. 123: 713–720.
Grases, F., Simonet, B. M., Vucenik, I., Prieto, R. M., Costa-Bauzá, A., March, J. G. & Shamsuddin, A. M. (2001) Absorption and excretion of orally administered inositol hexaphosphate (IP6 or phytate) in humans. Biofactors 15: 53–61.
Grases, F., Simonet, B. M., Vucenik, I., Perelló, J., Prieto, R. M. & Shamsuddin, A. M. (2002) Effects of exogenous inositol hexakiphosphate (InsP6) on the levels of InsP6 and of inositol trisphosphate (InsP3) in malignant cells, tissues and biological fluids. Life Sci. 71: 1535–1546.
Ferry, S., Matsuda, M., Yoshida, H. & Hirata, M. (2002) Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFB-mediated cell survival pathway. Carcinogenesis 23: 2031–2041.
Shamsuddin, A. M., Baten, A. & Lalwani, N. D. (1992) Effect of inositol hexaphosphate on growth and differentiation in K562 erythroleukemia cell line. Cancer Lett. 64: 195–202.
Deliliers, L. G., Servida, G., Fracchiolla, N. S., Ricci, C., Borsotti, C., Colombo, G. & Soligo, D. (2002) Effects of inositol hexaphosphate (IP6) on human normal and leukaemic hematopoietic cells. Br. J. Haematol. 117: 577–587
Sakamoto, K., Venkatraman, G. & Shamsuddin, A. M. (1993) Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). Carcinogenesis 14: 1815–1819.
Yang, G.-Y. & Shamsuddin, A. M. (1995) IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Anticancer Res. 15: 2479–2488
Arnold, J. T., Wilkinson, B. P., Sharma, S. & Steele, V. E. (1993) Evaluation of chemopreventative agents in different mechanistic classes using a rat epithelial cell culture transformation assay. Cancer Res. 73: 537–543.
Vucenik, I., Tantivejkul, K., Zhang, Z. S., Cole, K. E., Saied, I. & Shamsuddin, A. M. (1998) IP6 treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res. 18: 4083–4090.
Shamsuddin, A. M., Yang, G.-Y. & Vucenik, I. (1996) Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res. 16: 3287–3292
Shamsuddin, A. M. & Yang, G.-Y. (1995) Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis 16: 1975–1979
Singh, R. P., Agarwal, C. & Agarwal, R. (2003) Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Carcinogenesis 24: 555–563.
Huang, C., Ma, W.-Y., Hecht, S. S. & Dong, Z. (1997) Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3' kinase. Cancer Res. 57: 2873–2878.
Nickel, K. P. & Belury, M. A. (1999) Inositol hexaphosphate reduces 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase independent of protein kinase C isoform expression in keratinocytes. Cancer Lett. 140: 105–111.
Babich, H., Borenfreund, E. & Stern, A. (1993) Comparative toxicities of selected minor dietary non-nutrients with chemopreventive properties. Cancer Lett. 73: 127–133.
Vucenik, I., Kalebic, T., Tantivejkul, K. & Shamsuddin, A. M. (1998) Novel anticancer function of inositol hexaphosphate (IP6): inhibition of human rhabdomyosarcoma in vitro and in vivo. Anticancer Res. 18: 1377–1384.
Vucenik, I., Tomazic, V. J., Fabian, D. & Shamsuddin, A. M. (1992) Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma, a pilot study. Cancer Lett. 65: 9–13.
Ullah, A. & Shamsuddin, A. M. (1990) Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Carcinogenesis 11: 2219–2222.
Nelson, R. L., Yoo, S. J., Tanure, J. C., Andrianopoulos, G. & Misumi, A. (1989) The effect of iron on experimental colorectal carcinogenesis. Anticancer Res. 9: 1477–1482
Shivapurkar, N., Tang, Z. C., Frost, A. & Alabaster, O. (1996) A rapid dual organ rat carcinogenesis bioassay for evaluating the chemoprevention of breast and colon cancer. Cancer Lett. 100: 169–179.
Pretlow, T. P., O'Riordan, M. A., Somich, G. A., Amini, S. B. & Pretlow, T. G. (1992) Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13: 1509–1512.
Challa, A., Rao, D. R. & Reddy, B. S. (1997) Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea. Carcinogenesis 18: 2023–2026
Jenab, M. & Thompson, L. U. (2000) Phytic acid in wheat bran affects cell morphology, differentiation and apoptosis. Carcinogenesis 21: 1547–1552.
Thompson, L. U. & Zhang, L. (1991) Phytic acid and minerals: effect of early markers of risk for mammary and colon carcinogenesis. Carcinogenesis 12: 2041–2045
Hirose, M., Ozaki, K., Takaba, K., Fukushima, S., Shirai, T. & Ito, N. (1991) Modifying effects of the naturally occuring antioxidants -oryzanol, phytic acid, tannic acid and n-tritriacontane-16,18-dione in rat a wide-spectrum organ carcinogenesis model. Carcinogenesis 12: 1917–1921.
Vucenik, I., Zhang, Z. S. & Shamsuddin, A. M. (1998) IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice. Anticancer Res. 18: 4091–4096.
Estensen, R. D. & Wattenberg, L. W. (1993) Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice. Carcinogenesis 14: 1975–1977.
Wattenberg, L. W. (1995) Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis. J. Cell. Biochem. 22: 162–168.
Vucenik, I., Sakamoto, K., Bansal, M. & Shamsuddin, A. M. (1993) Inhibition of mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study. Cancer Lett. 75: 95–102
Vucenik, I., Yang, G.-Y. & Shamsuddin, A. M. (1995) Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis 16: 1055–1058
Vucenik, I., Yang, G. & Shamsuddin, A. M. (1997) Comparison of pure inositol hexaphosphate (IP6) and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr. Cancer 28: 7–13.
Hirose, M., Hoshiya, T., Akagi, K., Futakushi, M. & Ito, N. (1994) Inhibition of mammary gland carcinogenesis by green tea catechin and other naturally occuring antioxidants in Sprague-Dawley rats pretreated with 7,12-dimethylbenz[a]anthracene. Cancer Lett. 83: 149–156.
Ishikawa, T., Nakatsuru, Y., Zarkovic, M. & Shamsuddin, A. M. (1999) Inhibition of skin cancer by IP6 in vivo: initiation-promotion model. Anticancer Res. 19: 3749–3752.
Jariwalla, R. J., Sabin, R., Lawson, S., Bloch, D. A., Prender, M., Andrews, V. & Herman, Z. S. (1988) Effects of dietary phytic acid (phytate) on the incidence and growth rate of tumors promoted in Fisher rats by a magnesium supplement. Nutr. Res. 8: 813–827.
Vucenik, I., Ramakrishna, G., Tantivejkul, K., Anderson, L. & Ramljak, D. (1999) Inositol hexaphosphate (IP6) differentially modulates the expression of PKC in MCF-7 and MDA-MB 231 cells. Proc. Am. Assoc. Cancer Res. 40: 653.
Morisson, R. S., Shi, E., Kan, M., Yamaguchi, F., McKeehan, W., Rudnicka-Nawrot, M. & Palczewski, K. (1994) Inositol hexaphosphate (InsP6): An antagonist of fibroblast growth factor receptor binding and activity. In vitro cell. Dev. Biol. 30A: 783–789.
Baten, A., Ullah, A., Tomazic, V. J. & Shamsuddin, A. M. (1989) Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis 10: 1595–1598.
Walker, A. R. P., Fox, F. W. & Irving, J. T. (1948) Studies in human mineral metabolism. I. The effect of bread rich in phytate phosphorous on the metabolism of certain mineral salts with special reference to calcium. Biochem. J. 42: 452–462.
Cullumbine, H., Basnayake, V. & Lemottee, J. (1950) Mineral metabolism on rice diets. Br. J. Nutr. 4: 101–111.
Kelsay, J. L. (1987) Effect of fiber, phytic acid, and oxalic acid in the diet on mineral bioavailability. Am. J. Gastroenterol. 278: 983–986.
Sandstrom, B., Bugel, S., McGaw, B. A., Price, J. & Reid, M. D. (2000) A high oat-bran intakes does not impair zinc absorption in human when added to a low-fiber animal protein-based diet. J. Nutr. 130: 594–599.
Henneman, P. H., Benedict, P. H., Forbes, A. P. & Dudley, H. R. (1958) Idiopathic hypercalciuria. N. Engl. J. Med. 17: 802–807.
Grases, F., García-Gonsales, R., Torres, J. J. & Llobera, A. (1988) Effects of phytic acid on renal stone formation in rats. Scand. J. Urol. Nephrol. 32: 261–265.
Tran, H. C., Brooks, J., Gadwal, S., Bryant, J. L., Shamsuddin, A. M., Lunardi-Iskandar, Y. & Vucenik, I. (2003) Effect of inositol hexaphosphate (IP6) on AIDS neoplastic Kaposi's sarcoma, iatrogenic Kaposi's sarcoma and lymphoma. Proc. Am. Assoc Cancer Res. 44: 499.
Tantivejkul, K., Vucenik, I., Eiseman, J. & Shamsuddin, A. M. (2003) Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer. Breast Cancer Res. Treat. 79: 301–312
Vucenik, I., Tantivejkul, K., Ramakrishna, G., Anderson, L. M. & Ramljak, D. (2000) Antiproliferative effect inositol hexaphosphate (IP6) in breast cancer cells is mediated by increase in p27 and decrease in Rb protein phosphorylation. Proc. Am. Assoc. Cancer Res. 41: 339.
El-Sherbiny, Y., Cox, M. C., Ismail, Z. A., Shamsuddin, A. M. & Vucenik, I. (2001) G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res. 21: 2393–2404.
Tantivejkul, K., Vucenik, I. & Shamsuddin, A. M. (2003) Inositol hexaphosphate (IP6) inhibits key events of cancer metastases: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells. Anticancer Res. 23: 5 (in press).
Tantivejkul, K., Vucenik, I. & Shamsuddin, A. M. (2003) Inositol hexaphosphate (IP6) inhibits key events of cancer metastases: II. Effects on integrins and focal adhesions. Anticancer Res. 23: 5 (in press).
Vucenik, I., Passaniti, A., Tantivejkul, K., Eggleton, P., Vitolo, M. & Shamsuddin, A. M. (2002) Anti-angiogenic potential of inositol hexaphophate (IP6). Rev. Oncologia 4 (Suppl 1): 79.
Kelloff, G. J., Boone, C. W., Steele, V. E., Fay, J. R., Lubet, R. A., Crowell, J. A. & Sigman, C. C. (1994) Mechanistic consideration in chemopreventive drug development. J. Cell. Biochem. 20: 1–24.
Boone, C. W., Kelloff, G. J. & Malone, W. F. (1990) Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials. Cancer Res. 50: 2–9.
Katayama, T. (1995) Effect of dietary sodium phytate on the hepatic and serum levels of lipids and on the hepatic activities of NADH-generating enzymes in rats fed on sucrose. Biosci. Biotechnol. Biochem. 59: 1159–1160.
Katayama, T. (1997) Effects of dietary myo-inositol or phytic acid on hepatic concentrations of lipids and hepatic activities of lipogenic enzymes in rats fed on corn starch or sucrose. Nutr. Res. 4: 721–728.
Singh, A., Singh, S. P. & Bamezai, R. (1997) Modulatory influence of arecoline on the phytic acid-altered hepatic biotransformation system enzymes, sulfhydryl content and lipid peroxidation in a murine system. Cancer Lett. 117: 1–6.
Druzijanic, N., Juricic, J., Perko, Z. & Kraljevic, D. (2002) IP-6 & inositol: adjuvant to chemotherapy of colon cancer. A pilot clinical trial. Rev. Oncologia 4: 171.
Ohkawa, T., Ebisuno, S., Kitagawa, M., Marimoto, S., Miyazaki, Y. & Yasukawa, S. (1984) Rice bran treatment for patients with hypercalciuric stones: experimental and clinical studies. J. Urol. 132: 1140–1145.
Grases, F., March, J. G., Prieto, R. M., Simonet, B. M., Costa-Bauzá, A., Garcia-Raja, A. & Conte, A. (2000) Urinary phytate in calcium oxalate stone-formers and healthy people. Dietary effects on phytate excretion. Scand. J. Urol. Nephrol. 34: 162–164.
Jariwalla, R. J., Sabin, R., Lawson, S. & Herman, Z. S. (1990) Lowering of serum cholesterol and triglycerides and modulations by dietary phytate. J. Appl. Nutr. 42: 18–28.
Vucenik, I., Podczasy, J. J. & Shamsuddin, A. M. (1999) Antiplatelet activity of inositol hexaposphate (IP6). Anticancer Res. 19: 3689–3693.
Rao, P. S., Liu, X. K., Das, D. K., Weinstein, G. S. & Tyras, D. H. (1991) Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant. Ann. Thorac. Surg. 52: 908–912